| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9921115 | European Journal of Pharmacology | 2005 | 9 Pages |
Abstract
We conclude that 5-HT2A receptor antagonism enhanced reversal of amphetamine-induced inhibition by dopamine D2 antagonism in A10, suggesting that dopamine D2 receptor antagonism combined with 5-HT2A receptor antagonism may play a role in antipsychotic drug atypicality.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Johanna E. Olijslagers, Benny Perlstein, Taco R. Werkman, Andrew C. McCreary, Richard Siarey, Chris G. Kruse, Wytse J. Wadman,